Company / Operating Cash Flow per Share
Edesa Biotech, Inc. Operating Cash Flow per Share History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.52
FY2021
5-year range
-$3.13 / -$0.44
FY2017-FY2021
Trend
+19.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-3.13 in FY2018 to $-0.07 in FY2014.
Based on SEC 10-K filings.
-0.52 in FY2021.
Improved from $-3.13 to $-0.52 over the past 3 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating cash flow per share increased 19.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2014.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.52 | +19.7% |
| FY2020 | -$0.65 | +79.4% |
| FY2018 | -$3.13 | -618.4% |
| FY2017 | -$0.44 | +18.5% |
| FY2016 | -$0.53 | -49.6% |
| FY2015 | -$0.36 | -424.3% |
| FY2014 | -$0.07 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026